Page 2 of Sun Pharmaceutical Industries

Sun Pharmaceutical share price today, Sun Pharma, Sun Pharma stock, Sun Pharma share price

Sun Pharma slides 6% but Motilal Oswal recommends Buy: 3 reasons why

Sun Pharma slides 6% after weak Q1 FY26 results, but Motilal Oswal still recommends Buy—discover the three reasons to consider…

August 1, 2025 14:04 IST

Sun Pharma launches LEQSELVI in US for severe hair loss

Sun Pharma launches key alopecia drug in US, experts estimate $200–300 million market potential

Updated: July 15, 2025 14:30 IST

3 ‘Buy’ recommendation by Nomura, with up to 28% upside

Nomura issues ‘Buy’ calls on IndusInd Bank, Voltas, and Sun Pharma with up to 28% upside—read the full analysis to…

June 20, 2025 17:06 IST

Markets flat, Sensex swings 700 points, IT stocks shine

Pharma stocks are down as much as 10%. Read to know why…

Pharma stocks plummet up to 10% amid looming US tariffs. Discover the impact!

February 19, 2025 10:10 IST

Sun Pharma share price today, Sun Pharma share news today

Sun Pharma shares slip over 3% after US court’s ruling on LEQSELVI launch

Sun Pharmaceutical shares have delivered impressive gains across multiple time frames, reflecting strong investor interest. Over the past three months,…

Updated: November 4, 2024 11:18 IST

Sun Pharma, novel therapy, skin disorders, skin disorders in India, Sun Pharma news, healthcare news, pharma news,

Sun Pharma launches novel therapy for skin disorders in India

Skin and soft tissue infections are the most common type of infections constituting, around 29-32% of all infections in 2018-2019…

August 23, 2024 15:06 IST

billionaire kids, ananya birla, anant ambani money, billionaire kids net worth, know billionaire kids, who are indian rich kids, who are billionaires kids in india, ambani daighter, isha ambani, ananya birla, rich kids in india, billionaires in india

From Isha Ambani and Ananya Birla to Karan Adani and Jyoti Kabra: Meet 16 heirs of India’s billionaire families

Their leadership and vision are pivotal in maintaining the competitive edge and ensuring the continued growth and relevance of their…

Updated: June 24, 2024 13:21 IST

Sun Pharma Q4 Results: Profit rises by 33.8% to Rs 2654.58 crore, dividend of Rs 5 announced

Sun Pharma posted revenue from operations at Rs 11,982.90 crore, up 9.6 per cent as against Rs 10,930.67 crore during…

May 22, 2024 15:34 IST

Dilip Sanghvi, Dilip Sanghvi net worth, Dilip Sanghvi lifestyle, Dilip Sanghvi forbes, who is Dilip Sanghvi, Sun Pharma, Dilip Sanghvi Sun Pharma, lifestyle

Who is Indian billionaire Dilip Sanghvi, the man behind Sun Pharma? Know about his Rs 15.65 lakh crore net worth

Founder of Sun Pharma, Shanghvi commands a business empire generating $5.4 billion (approximately Rs 44,971 crore) in revenue.

Updated: December 21, 2023 00:37 IST

Sun Pharma, Taro, acquisition, shares, investment, merger, generic dermatology market

Sun Pharma’s shares advance on Q2 results; Should you buy, hold or sell the stock?

Sun Pharma’s share price gained 1.48% in the last five days, while it dropped 1.13% in the last one month.…

Updated: November 2, 2023 11:28 IST

Sun Pharma, Eye diseases, Eye disorder, dry eyes, trial results, healthcare news, pharma news,

Sun Pharma posts Q1 profit at Rs 2022.54 cr on low profitability at Taro; MD says well positioned to meet FY24 guidance

Sun Pharmaceutical posted revenue from operations at Rs 11,940.84 crore, up 11 per cent as against Rs 10,761.76 crore during…

August 4, 2023 11:41 IST

Dilip Shanghvi net worth, who is dilip shanghvi, dilip shanghvi journey,, Sun Pharmaceutical Industries Limited, entrepreneur, healthcare industry, affordable medicines, generic and branded pharmaceutical products, business family, net worth, low-key lifestyle, philanthropy, sun foundation.

Meet Padma Shri Dilip Shanghvi, a visionary who transformed Indian healthcare industry: Know about his journey, education, net worth and more

In this article, we will take a look at Shanghvi’s journey, family, education, net worth and more.

April 29, 2023 09:00 IST

Sun Pharma, Sun Pharmaceutical industries, Israel Makov, health news, pharma news,

Sun Pharma’s Chairman Israel Makov to retire this month

In a statement, the company claimed that Sun Pharma transformed from a US$ 1.7 billion organisation focusing on India and…

August 3, 2022 11:23 IST

Sun Pharmaceuticals rating: Buy | Specialty sales boost prospects

Quarter performance beat estimates; FY23/24e EPS up 1/3%; target price revised to Rs 1,089; ‘Buy’ retained.

August 2, 2022 01:30 IST

Alembic Pharmaceuticals, PAS approval, USFDA approval, Pregabalin Capsules, health news, pharma news,

Sun Pharma stock falls 3.5% intraday; analysts bullish, see up to 20% upside potential; what should you do?

Sun Pharmaceutical Industries’ share price fell 3.5 per cent intraday on Monday, despite a 43 per cent on-year growth in…

August 1, 2022 15:06 IST

Nifty could fall to 14592 in coming weeks; sell these two stocks to pocket gains, charts show downtrend

Nifty could now be headed towards the next major intermediate support of 14592 in the coming weeks.

Updated: June 23, 2022 09:07 IST

Sun Pharmaceuticals rating – Buy: One-offs hit bottomline in Q4FY22

Traction in specialty sales was maintained; FY23/24e EPS down 3.3/3.5%; ‘Buy’ retained with revised target price of Rs 1,040

June 6, 2022 02:15 IST

sun pharma, sun pharma share price, sun pharm q4

Sun Pharma share price falls 2% after Q4 results fail to beat estimates; brokerages see up to 22% upside

Sun Pharmaceuticals share price fell 2% to hit an intraday low of Rs 856.7 on NSE on Tuesday after the…

May 31, 2022 10:11 IST

Related News

US tourist visa: B1/B2 visa approved, officer tells applicant ‘we need people like you’

Meta CEO Mark Zuckerberg’s highest-paid employee Alexandr Wang says the next Bill Gates is a 13-year-old ‘vibe coder’: Here’s why

From Zoho’s Sridhar Vembu to Google CEO Sundar Pichai: Why top tech leaders are talking about rise of Vibe Coding

Zoho founder Sridhar Vembu to Google CEO Sundar Pichai: Why top tech leaders are talking about rise of Vibe Coding

FY 2027 H-1B Cap season, H-1B 2027 new rules, H-1B 100k fee for F-1 students, h1b cap registration 2027 dates, H-1B season 2027, H-1B cap season 2027, H-1B Cap FY 2027 Lottery Timeline, Process, Dates

H-1B Cap FY 2027: Lottery ends, wage-based selection begins; $100,000 fee introduced

38 countries will now face US visa bond rule of up to $15,000

US mandates bonds for B1/B2 visas from 38 high-risk nations – Is India on the list?

Inside the Rs 2,000 cr Rajasthan mid-day meal fraud: Fake invoices & COVID supply packs

India News46 min ago

The Rajasthan ACB has filed an FIR against 21 people, including government officials and private suppliers, for a Rs 2,000 crore scam in the mid-day meal scheme during Covid-19. Officials and firms allegedly collaborated to fake billing, forge documents, and misuse public funds. The ACB is investigating and will take strict action against the guilty parties.

View all shorts